deciphering deliver trial - dapa vs placebo in heart failure with preserved ejection fraction
Published 1 year ago • 118 plays • Length 43:15Download video MP4
Download video MP3
Similar videos
-
7:32
dapa-hf clinical trial i dapagliflozin i hfref
-
13:17
empagliflozin in heart failure with a preserved ejection fraction
-
4:46
hfa 23: dapa-hf and deliver: kccq in patients with varying ejection fraction
-
6:57
hfa 2020: dapagliflozin and diuretic use in patients with hfref in dapa-hf — dr alice m jackson
-
12:46
heart failure with preserved ejection fraction: 5 keys to know
-
15:47
hfpef: ongoing challenges and exciting breakthroughs - natasha aleksova
-
1:28:07
a deep dive into the diagnosis of hfpef
-
5:21
acc 23: evaluation of the mechanism of benefit for dapagliflozin in hfpef
-
3:50
dr. mcmurray discusses the dapa-hf trial of dapagliflozin in systolic heart failure
-
1:19:48
emperor preserved trial national webinar pinnacle epp 2
-
6:27
pardeep jhund, esc 2022: dapagliflozin for heart failure, pooled analysis of dapa-hf and deliver
-
26:10
diagnosis and treatment of heart failure with preserved ejection fraction
-
2:28
lbct dapagliflozin and atrial fibrillation in hfpef in deliver | esc congress 2022
-
9:35
preserved-hf: support for dapagliflozin to improve hfpef health status | mikhail kosiborod
-
10:57
best practices for starting sglt2 inhibitors in hfpef treatment
-
8:41
delivering the details on dapagliflozin in heart failure
-
6:24
deliver results - scott d. solomon, md
-
1:26:09
challenges in the diagnosis of heart failure with preserved ejection fraction.
-
2:53
dapagliflozin for heart failure: a pooled analysis of dapa-hf and deliver
-
1:12
results of dapa-hf - dr. john j mcmurray
-
6:04
canadian perspectives on esc 2022 - deliver trial